Tissue microarrays for high-throughput molecular profiling of tumor specimens

被引:3310
作者
Kononen, J
Bubendorf, L
Kallioniemi, A
Bärlund, M
Schraml, P
Leighton, S
Torhorst, J
Mihatsch, MJ
Sauter, G
Kallioniemi, OP
机构
[1] Natl Human Genome Res Inst, Canc Genet Lab, NIH, Bethesda, MD 20892 USA
[2] Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland
[3] Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33521 Tampere, Finland
[4] Tampere Univ Hosp, FIN-33521 Tampere, Finland
[5] Beecher Instruments, Silver Spring, MD USA
关键词
D O I
10.1038/nm0798-844
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many genes and signalling pathways controlling cell proliferation, death and differentiation, as well as genomic integrity, are involved in cancer development. New techniques, such as serial analysis of gene expression and cDNA microarrays, have enabled measurement of the expression of thousands of genes in a single experiment, revealing many new, potentially important cancer genes(1,2). These genome screening tools can comprehensively survey one tumor at a time; however, analysis of hundreds of specimens from patients in different stages of disease is needed to establish the diagnostic, prognostic and therapeutic importance of each of the emerging cancer gene candidates. Here we have developed an array-based high-throughput technique that facilitates gene expression and copy number surveys of very large numbers of tumors. As many as 1000 cylindrical tissue biopsies from individual tumors can be distributed in a single tumor tissue microarray, Sections of the microarray provide targets for parallel in situ detection of DNA, RNA and protein targets in each specimen on the array, and consecutive sections allow the rapid analysis of hundreds of molecular markers in the same set of specimens. Our detection of six gene amplifications as well as p53 and estrogen receptor expression in breast cancer demonstrates the power of this technique for defining new subgroups of tumors.
引用
收藏
页码:844 / 847
页数:4
相关论文
共 22 条
  • [1] ALLRED DC, 1990, ARCH SURG-CHICAGO, V125, P107
  • [2] Barbareschi M, 1997, INT J CANCER, V74, P171, DOI 10.1002/(SICI)1097-0215(19970422)74:2<171::AID-IJC5>3.0.CO
  • [3] 2-W
  • [4] Barlund M, 1997, GENE CHROMOSOME CANC, V20, P372, DOI 10.1002/(SICI)1098-2264(199712)20:4<372::AID-GCC8>3.0.CO
  • [5] 2-Z
  • [6] BATTIFORA H, 1990, LAB INVEST, V63, P722
  • [7] BATTIFORA H, 1986, LAB INVEST, V55, P244
  • [8] ASSOCIATION OF INT2/HST1 COAMPLIFICATION IN PRIMARY BREAST-CANCER WITH HORMONE-DEPENDENT PHENOTYPE AND POOR PROGNOSIS
    BORG, A
    SIGURDSSON, H
    CLARK, GM
    FERNO, M
    FUQUA, SAW
    OLSSON, H
    KILLANDER, D
    MCGURIE, WL
    [J]. BRITISH JOURNAL OF CANCER, 1991, 63 (01) : 136 - 142
  • [9] Courjal F, 1997, CANCER RES, V57, P4360
  • [10] DeRisi J, 1996, NAT GENET, V14, P457